Megaloblastic anemia should be treated be treated with both folic acid vitamin B12 because –
**Core Concept**
Megaloblastic anemia is a type of anemia characterized by the production of abnormally large red blood cells that are not able to function properly. This condition is primarily caused by a deficiency in either vitamin B12 or folate, leading to impaired DNA synthesis and cell division.
**Why the Correct Answer is Right**
Both vitamin B12 and folate are essential for the synthesis of DNA and the production of red blood cells. A deficiency in either of these nutrients can lead to megaloblastic anemia. Vitamin B12 deficiency causes a defect in the synthesis of DNA by inhibiting the activity of dihydrofolate reductase, an enzyme that converts dihydrofolate to tetrahydrofolate, a crucial cofactor for DNA synthesis. Folate deficiency also leads to impaired DNA synthesis by reducing the availability of tetrahydrofolate. Treating megaloblastic anemia with both vitamin B12 and folate addresses the underlying cause of the condition, promoting the production of normal-sized red blood cells.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not provide a specific reason for treating megaloblastic anemia with both vitamin B12 and folate.
**Option B:** This option is incorrect because it implies that only one of the two nutrients is necessary for treatment, which is not the case.
**Option C:** This option is incorrect because it does not provide a clear explanation for the need for both vitamin B12 and folate in treating megaloblastic anemia.
**Clinical Pearl / High-Yield Fact**
It is essential to note that both vitamin B12 and folate deficiencies can present with similar clinical symptoms, making it crucial to assess for both deficiencies in patients with megaloblastic anemia. A trial of vitamin B12 supplementation is often recommended before folate supplementation, as some patients may have a vitamin B12 deficiency that is not immediately apparent.
**Correct Answer:** C. Both are necessary to address the underlying cause of megaloblastic anemia.